InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by MCGOVERN MARK E, Director. Officer active across 1 companies, notably Esperion Therapeutics, Inc.. In total, 2 filings have been published. The latest transaction was disclosed on 27 May 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
012,376 shares0
Common Stock
SEC:0001628280-21-011360·
012,376 shares0
Common Stock
SEC:0001628280-21-011360:0·
2 of 2 declarations
About MCGOVERN MARK E
Mark E. McGovern serves as a Director at Esperion Therapeutics, Inc. In this role, he contributes to the company's strategy and governance. His expertise in the biopharmaceutical sector is an asset to the board.
